190 related articles for article (PubMed ID: 31588654)
21. The recognition and treatment of autoimmune epilepsy in children.
Suleiman J; Dale RC
Dev Med Child Neurol; 2015 May; 57(5):431-40. PubMed ID: 25483277
[TBL] [Abstract][Full Text] [Related]
22. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
23. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.
Toledano M; Britton JW; McKeon A; Shin C; Lennon VA; Quek AM; So E; Worrell GA; Cascino GD; Klein CJ; Lagerlund TD; Wirrell EC; Nickels KC; Pittock SJ
Neurology; 2014 May; 82(18):1578-86. PubMed ID: 24706013
[TBL] [Abstract][Full Text] [Related]
24. Predictive models in the diagnosis and treatment of autoimmune epilepsy.
Dubey D; Singh J; Britton JW; Pittock SJ; Flanagan EP; Lennon VA; Tillema JM; Wirrell E; Shin C; So E; Cascino GD; Wingerchuk DM; Hoerth MT; Shih JJ; Nickels KC; McKeon A
Epilepsia; 2017 Jul; 58(7):1181-1189. PubMed ID: 28555833
[TBL] [Abstract][Full Text] [Related]
25. [Autoimmune factors and epilepsy].
Wu Y; Liu A
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1452-1457. PubMed ID: 29317588
[TBL] [Abstract][Full Text] [Related]
26. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.
Vincent A; Irani SR; Lang B
Curr Opin Neurol; 2010 Apr; 23(2):144-50. PubMed ID: 20164770
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations of patients with CASPR2 antibodies.
Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
[TBL] [Abstract][Full Text] [Related]
28. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures.
Liimatainen S; Peltola M; Fallah M; Kharazmi E; Haapala AM; Peltola J
Eur J Neurol; 2009 Jan; 16(1):134-41. PubMed ID: 19049505
[TBL] [Abstract][Full Text] [Related]
29. Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.
Bien CG
Front Immunol; 2018; 9():703. PubMed ID: 29696018
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune Epilepsy: The Evolving Science of Neural Autoimmunity and Its Impact on Epilepsy Management.
Quek AML; O'Toole O
Semin Neurol; 2018 Jun; 38(3):290-302. PubMed ID: 30011410
[TBL] [Abstract][Full Text] [Related]
31. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
32. Circulating neural antibodies in unselected children with new-onset seizures.
Garcia-Tarodo S; Datta AN; Ramelli GP; Maréchal-Rouiller F; Bien CG; Korff CM
Eur J Paediatr Neurol; 2018 May; 22(3):396-403. PubMed ID: 29291919
[TBL] [Abstract][Full Text] [Related]
33. Nonlesional late-onset epilepsy: Semiology, EEG, cerebrospinal fluid, and seizure outcome characteristics.
Süße M; Hamann L; Flöel A; von Podewils F
Epilepsy Behav; 2019 Feb; 91():75-80. PubMed ID: 29941211
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort study.
von Podewils F; Suesse M; Geithner J; Gaida B; Wang ZI; Lange J; Dressel A; Grothe M; Kessler C; Langner S; Runge U; Bien CG
Epilepsia; 2017 Sep; 58(9):1542-1550. PubMed ID: 28681401
[TBL] [Abstract][Full Text] [Related]
35. Validation of different predictive scoring scales in patients with new-onset epileptic seizures or epilepsy related to neuronal surface antibody-mediated autoimmune encephalitis.
Duan Y; Zhang Z; Zhao X; Cheng H; Zhang S; Guo S; Jin B; Wu X; Aung T
Epilepsy Behav; 2023 Oct; 147():109403. PubMed ID: 37660404
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune epilepsies.
Irani SR; Bien CG; Lang B
Curr Opin Neurol; 2011 Apr; 24(2):146-53. PubMed ID: 21358545
[TBL] [Abstract][Full Text] [Related]
37. [Immune-mediated epilepsy and encephalopathy].
Kramme C; Bien CG
Nervenarzt; 2013 Apr; 84(4):442-9. PubMed ID: 23334452
[TBL] [Abstract][Full Text] [Related]
38. Immune-mediated epilepsy with GAD65 antibodies.
Li X; Guo Q; Zheng Z; Wang X; Liu S
J Neuroimmunol; 2020 Apr; 341():577189. PubMed ID: 32087461
[TBL] [Abstract][Full Text] [Related]
39. GAD-65 autoantibody associated epilepsy.
Dimova R; Grozeva G; Chakarova N; Tsarkova P; Tankova T
J Pediatr Endocrinol Metab; 2020 May; 33(6):817-820. PubMed ID: 32436860
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune Epilepsy.
Husari KS; Dubey D
Neurotherapeutics; 2019 Jul; 16(3):685-702. PubMed ID: 31240596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
